Manufacturer's investigation conclusion: the report of bleeding from the apical cuff site could not be confirmed through this evaluation.The patient remains ongoing on heartmate 3 left ventricular assist system (lvas), serial number mlp-(b)(6) and no further related events have been reported at this time.The relevant sections of the device history records for mlp-(b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.Review of the lvad final assembly device history record showed that the cuff lock installed on mlp-(b)(6) passed all inspection and testing steps.The heartmate 3 instructions for use (ifu), rev.C, is currently available.Section 1 of the ifu ¿introduction¿ lists bleeding as an adverse event that may be associated with the use of the heartmate 3 left ventricular assist system.Section 5, ¿surgical procedures¿ (under ¿preparing the ventricular apex site¿), contains information regarding the preparation of the ventricular apex site, including how to affix the apical cuff to the left ventricle.This section cautions that after the apical cuff has been sewn to the heart, the metal ring on the apical cuff should extend above the felt surface to allow proper engagement and locking with the slide lock of the heartmate 3 left ventricular assist device.This section suggests tying the sutures of the apical cuff tight with 6 to 7 throws on each knot and instructs the user to ensure that apposition between the myocardial tissue and the cuff felt is continuous and sufficiently forceful to prevent bleeding.Furthermore, section 5 states that during the implant process, a complete backup system (implant kit and external components) must be available on-site and in close proximity for use in an emergency.No further information was provided.The manufacturer is closing the file on this event.
|